Nature Reviews Drug Discovery Q1 Unclaimed
Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering a broad scope, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in areas such as new drug approvals, patent law and emerging industry trends and strategies. It has an SJR impact factor of 11.296.
Nature Reviews Drug Discovery focuses its scope in these topics and keywords: drug, strategies, drugs, clinical, human, cancer, antibodies, therapeutic, catalysts, discoverycan, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Non Open Access
Type of publications:
Publication frecuency: -
- €
Inmediate OA- €
Embargoed OA0 €
Non OAMetrics
11.296
SJR Impact factor348
H Index244
Total Docs (Last Year)684
Total Docs (3 years)7551
Total Refs11388
Total Cites (3 years)233
Citable Docs (3 years)16.62
Cites/Doc (2 years)30.95
Ref/DocOther journals with similar parameters
Journal of Clinical Oncology Q1
Annals of Oncology Q1
Annual Review of Public Health Q1
Psychological science in the public interest : a journal of the American Psychological Society Q1
Accounts of Chemical Research Q1
Compare this journals
Aims and Scope
Best articles by citations
Overcoming inhibition
View moreNeuropeptide gene polymorphisms and human behavioural disorders
View moreBiodegradable multi-drug dispenser
View moreHow Goldilocks is partial to dopamine receptors
View moreFDA approves first-in-class SYK inhibitor
View moreLighting up targets with reporter ribozymes
View moreHitting the MARCKS
View moreRegulating the beat
View moreWhen drugs unintentionally affect gut bugs
View moreGetting the measure of stroke
View moreParalyzing the two-faced BOTOX
View moreNew forms of attack
View moreBetting on biogenerics
View moreBACE failures lower AD expectations, again
View moreMining for bioinformatics jobs
View moreBirds of a feather...
View moreCertolizumab pegol
View moreCorrection: Cox-2 and beyond: Approaches to prostagland in inhibition in human disease
View moreChallenges and opportunities in animal drug development: a regulatory perspective
View moreLegless - but still the way forward
View moreScientists slam rationale behind largest HIV vaccine trial
View moreTargeting the Nogo Receptor to Treat Central Nervous System Injuries
View moreEngineering a smoother ride
View moreShedding light on a silent pathway
View more
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments